Industries

• Reset all ×
• Healthcare & Life Sciences ×
• China ×

Showing 31–40 of 44 results

Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 

  Bladder Cancer Market in China

  According to StrategyHelix, the bladder cancer market in China, in terms of volume, is expected to expand at a CAGR of 3.1% over the analysis period of 2021 to 2027.

  USD 5
• 

  Pancreatic Cancer Market in China

  According to a statistic by StrategyHelix, the pancreatic cancer market in China, in terms of volume, is expected to expand at a CAGR of 3.3% during the forecast period (2021-2027).

  USD 5
• 

  Lymphoma Market in China

  According to StrategyHelix, the lymphoma market in China, in terms of volume, is expected to expand at a CAGR of 2.3% in the next five years.

  USD 10
• 

  Urothelial Cancer Market in China

  According to a statistic by StrategyHelix, the urothelial cancer market in China, in terms of volume, is expected to expand at a CAGR of 3.2% from 2021 through 2027.

  USD 5
• 

  Gastric Cancer Market in China

  The gastric cancer market in China was estimated at 470 thousand units in 2020 and is anticipated to reach 579 thousand units by 2027, progressing at a CAGR of 3% throughout the forecast period, according to StrategyHelix.

  USD 10
• 

  Breast Cancer Market in China

  According to StrategyHelix, the breast cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.2% from 2021 through 2027.

  USD 5
• 

  Non-small-cell Lung Carcinoma (NSCLC) Market in China

  At 3% CAGR, the non-small-cell lung carcinoma (NSCLC) market in China is projected to reach 967 thousand units by 2027, according to data and analytics company StrategyHelix.

  USD 10
• 

  Nasopharyngeal Cancer Market in China

  According to a statistic by StrategyHelix, the nasopharyngeal cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.2% in the next five years.

  USD 5
• 

  Head and Neck Cancer Market in China

  The head and neck cancer market in China, in terms of volume, is expected to expand at a CAGR of 1.7% from 2021 through 2027, according to data and analytics company StrategyHelix.

  USD 5
• 

  Oncology Drug Market in China

  The oncology drug market in China is poised to grow at a CAGR of around 13.3% over the analysis period of 2021 to 2027, according to data and analytics company StrategyHelix.

  USD 10